Off-label use of stents investigated

Mar 07, 2007

A federal committee is investigating the off label use of drug-coated heart stents by U.S. doctors, The Wall Street Journal reported Tuesday.

The U.S. House Committee on Oversight and Government reform has asked Boston Scientific and Johnson & Johnson, makers of the stents to submit marketing materials and clinical data for review.

About 60 percent of drug-coated stents, used to open clogged arteries, are prescribed outside of U.S. Food and Drug Administration boundaries, the Journal said.

Stents are commonly given to patients who have had heart attacks, despite a lack of rigorous testing in such patients, the report said.

While doctors are allowed to prescribe stents to off-label patients, "manufacturers can't encourage off-label use," the Journal said.

Copyright 2007 by United Press International

Explore further: US appeals court upholds delay in Alzheimer's drug swap

Related Stories

ICANN chief stepping down in early 2016

36 minutes ago

The head of the group that oversees all Internet addresses will step down early next year, after a plan to end US oversight of the key nonprofit organization.

HP sells stake in China unit for $2.3 bn

52 minutes ago

Hewlett-Packard announced Thursday it was selling a 51 percent stake in its China-based server business, creating a joint venture with Tsinghua Holdings that will be a sector leader in China.

Recommended for you

US appeals court upholds delay in Alzheimer's drug swap

4 hours ago

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.